Form 483

Opella Healthcare International SAS Form 483, 2017-06-23

FDA issued a Form 483 to Opella Healthcare International SAS on 2017-06-23 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Opella Healthcare International SAS · Compiegne, France · Issued June 23, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Jun 2017
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.63

Equipment Design, Size and Location

Cited by Satheesh Thomas

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere